Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Pretreatment Lymphocyte to Monocyte Ratio on Clinical Outcome for Patient With HCC

NCT03869151 is registered in ClinicalTrials.gov with Amany Aboalenen Amin as lead sponsor.

NCT NCT03869151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03869151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Pretreatment Lymphocyte to Monocyte Ratio on Clinical Outcome for Patient With HCC
Lead sponsor
Amany Aboalenen Amin
Phase
Observational
Overall status
Unknown status
Start date
April 5, 2019
Completion date
March 31, 2020
Enrollment
1 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma